Skip to main content

T 4184 Pill - gray capsule/oblong, 14mm

Pill with imprint T 4184 is Gray, Capsule/Oblong and has been identified as Pazopanib Hydrochloride 200 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Pazopanib is used in the treatment of Soft Tissue Sarcoma; Renal Cell Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Pazopanib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T 4184

Pazopanib hydrochloride 200 mg T 4184

Pazopanib Hydrochloride

Imprint
T 4184
Strength
200 mg
Color
Gray
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00480-4184

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.